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Abstract: Lactococcosis, particularly that caused by Lactococcus garvieae, is a major re-emerging
bacterial disease seriously affecting the sustainability of aquaculture industry. Medicinal herbs
and plants do not have very much in vitro antagonism and in vivo disease resistance towards
lactococcosis agents in aquaculture. Most in vitro studies with herbal extractives were performed
against L. garvieae with no strong antibacterial activity, but essential oils, especially those that contain
thymol or carvacrol, are more effective. The differences exhibited by the bacteriostatic and bactericidal
functions for a specific extractive in different studies could be due to different bacterial strains or
parts of chemotypes of the same plant. Despite essential oils being shown to have the best anti-L.
garvieae activity in in vitro assays, the in vivo bioassays required further study. The extracts tested
under in vivo conditions presented moderate efficacy, causing a decrease in mortality in infected
animals, probably because they improved immune parameters before challenging tests. This review
addressed the efficacy of medicinal herbs to lactococcosis and discussed the presented gaps.
Keywords: lactococcosis; Lactococcus garvieae; phytotherapy; aquaculture
1. Introduction
The aquaculture industry has seen a rapid acceleration in its development; as the most
rapidly growing global agricultural sector, the aquaculture sector is now responsible for
producing more than 50% of global seafood, with an average growth of 5.3% per year in
the period 2001–2018 [1]. It is important to note that despite such rapid development, it is
vitally important to pay attention to the processes used in order to maintain the quality
standards of aquaculture products. Frequent worldwide outbreaks of infectious diseases,
including bacterial diseases, are now one of major obstacles causing both huge financial
losses and significant reductions in the quality standards of aquaculture production [2–4].
The initial reports of Gram-positive bacterial agents involved in systemic bacterial diseases
in aquaculture species including rainbow trout (Oncorhynchus mykiss) came from Eastern
Asian regions, and, since then, diseases caused by several different Gram-positive bacteria
belonging to genera of Lactococcus [5,6], Streptococcus [7], Vagococcus [8], and Carnobac-
terium [9] have dramatically increased in global aquaculture [10–12].
The genus Lactococcus, which has the ability to produce lactic acid from glucose, con-
sists of eleven species that can be divided in two phylogenetic groups: the first group
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contains L. garvieae, Lactococcus lactis, Lactococcus taiwanensis, Lactococcus hircilactis, Lacto-
coccus fujiensis, and Lactococcus formosensis, and the second group comprises Lactococcus
laudensis, Lactococcus raffinolactis, Lactococcus chungangensis, Lactococcus plantarum, and
Lactococcus piscium [13]. Some strains, mainly L. lactis, are widely applied in industrial
processes as starter cultures, probiotics and protective cultures [14–16]. L. lactis is gen-
erally recognized as safe by the US FDA and is suitable for the qualified presumption
of safety approaches [17]. In recent years, attention has been paid to other species of L.
garvieae, L. raffinolactis, L. plantarum, and L. piscium as potential pathogens of aquaculture
species [18–21].
Among the species of Lactococcus genus, L. garvieae has been highlighted as one of
the most serious global bacterial pathogens in the aquaculture sector, both in freshwater
and marine fish, especially at water temperatures of >15 ◦C, but L. lactis and L. piscium
seem to be limited to some highly valuable aquaculture species, such as salmonids and
sturgeons, at various water temperatures [11,22,23]. Due to the widespread sources of
the bacterial agents and disease spreading, as well as the heterogenicity of the bacterial
stains implicated in the disease outbreaks, both vaccination and chemotherapy require
more attention in future. The application of co-friendly environmental substances, such
as medicinal herbs and probiotics, are nowadays a potential best alternative to antibiotic
therapy and an immune enhancer against such bacterial diseases. This review addresses
and discusses the efficacy of medicinal herbs and plants as means of prevention or for the
protection of susceptible aquaculture species against diseases caused by L. garvieae and
other Lacococcus species reported as the causative agents of lactococcosis in aquaculture.
2. Diseases Caused by Lactococcus Members in Aquaculture
2.1. Disease Caused by L. garvieae
Lactococcosis, caused by L. garvieae, is a systemic hyperacute bacterial disease causing
general hemorrhagic symptoms in susceptible aquatic organisms [24,25]. Based on their
ability to agglutinate serum raised against L. garvieae, there are two groups of bacterial
serotypes: non-agglutinating (KG−) and agglutinating (KG+) phenotypes [26]. The affected
fish first become relatively anorexic, with a visible darkening of skin color, showing sluggish
movement and abnormal behaviors, such as erratic and spiral swimming [11,24]. In the
later stages of the disease the affected fish display signs of swollen abdomen, anal prolapsus,
lateral or bilateral exophthalmia (Figure 1A,B), cataracts (Figure 1C), congestion of the
internal organs, spleen and liver enlargement, accumulation of turbid ascitic fluid in the
peritoneal cavity, and the presence of exudates in the brain [11,22,27,28]. Acute hyperemia
and or extensive hemorrhage and petechiae of the organs, including the mucosal layers of
the intestine, can also be seen in the diseased fish (Figure 1F), and in some cases the diseased
fish show signs of explosion in the eyes prior to the loss of their eyes (Figure 1D,E) [11,22,29].
In advanced forms of the disease, a Gram stain preparation of hematopoietic tissue imprints,
including spleen and kidney, can exhibit huge numbers of Gram-positive coccoid cells in
single or chain forms (Figure 1G).
Pericarditis, peritonitis and meningitis, diffuse hemorrhage in the sclera of the eye,
focal necrosis in the spleen and clumps of bacteria, hemorrhage in serosa of the swim
bladder and in the interstitium of the skeletal muscles, degeneration and necrosis in
epithelia of the stomach glands and their lumens full of necrotic material are among the
identified histopathological findings in lactococcosis infection caused by L. garvieae [30–32].
Vascular changes in spleen and kidneys [33] and degenerations in the tubular epithelium
with an increase in the melano-macrophage centers, hemorrhage in the form of a hematoma
covering the myocardium and the bulbus arteriosa, petechial hemorrhage, vascular change,
degeneration and necrosis are major histopathological findings. Lipid and ell infiltration
in the liver, hemorrhage and vascular change in muscles, and petechial hemorrhage and
edema in the gills are further microscopic changes reported in the infected fish by L.
garvieae [31]. The severity of such pathological changes is, however, varied and depended
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on various factors, including level of virulent of bacterial strain, fish species and size and
level of health management criteria, such as water temperature.




Figure 1. Rainbow trout growing in race ways and affected by L. garvieae showing: (A) typical bilateral exophthalmia and 
no change in the color skin, (B) typical bilateral exophthalmia and beginning of skin color change, (C) typical cataract and 
dark color, (D) bilateral exophthalmia and a complete loss of the eye, (E) darkening of body and an explosion of the eye, 
(F) hemorrhage of intestine, (G) direct Gram stain preparation of spleen of diseased fish showing huge numbers of Gram-
positive coccoid cells confirmed as L. garvieae by phenotyping and molecular works. (photos by Professor Mehdi Soltani). 
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focal necrosis in the spleen and clumps of bacteria, hemorrhage in serosa of the swim 
bladder and in the interstitium of the skeletal muscles, degeneration and necrosis in epi-
thelia of the stomach glands and their lumens full of necrotic material are among the iden-
tified histopathological findings in lactococcosis infection caused by L. garvieae [30–32]. 
Vascular changes in spleen and kidneys [33] and degenerations in the tubular epithelium 
with an increase in the melano-macrophage centers, hemorrhage in the form of a hema-
toma covering the myocardium and the bulbus arteriosa, petechial hemorrhage, vascular 
change, degeneration and necrosis are major histopathological findings. Lipid and ell in-
filtration in the liver, hemorrhage and vascular change in muscles, and petechial hemor-
rhage and edema in the gills are further microscopic changes reported in the infected fish 
by L. garvieae [31]. The severity of such pathological changes is, however, varied and de-
pended on various factors, including level of virulent of bacterial strain, fish species and 
size and level of health management criteria, such as water temperature. 
Evidence of bacterial cells in fish macrophage in tissues of spleen, kidney, heart (en-
dothelial), and peritoneum are evidence of a septicemic condition, suggesting that macro-
phages play a key role in the host immune response to L. garvieae infection. However, 
intra-macrophage resistance of the bacteria can cause a spread of the pathogen to all tis-
sues of fish by macrophages. Further, as in the young fish phagocytosis by macrophage 
activation may not be sufficient, thus, pathogenesis is a determinant factor, and the dis-
ease can progress. 
Several factors play roles in the virulence of L. garvieae. Polysaccharide capsule is the 
major virulence factor in L. garvieae infection [29]. The capsulated strains resist to phago-
cytosis, but some non-capsulated strains are pathogenic in fish causing high mortality in 
Figure 1. Rainbo trout gro ing in race ays and affected by L. garvieae sho ing: (A) typical bilateral exophthal ia and
no change in the color skin, (B) typical bilateral exophthalmia and beginning of skin color change, (C) typical cataract
and dark color, (D) bilateral exophthalmia and a complete loss of the eye, (E) darkening of body and an explosion of
the eye, (F) hemorrhage of intestine, (G) direct Gram stain preparation of spleen of diseased fish showing huge numbers
of Gram-positive coccoid cells confirmed as L. garvieae by phenotyping and molecular works. (photos by Professor
Mehdi Soltani).
Evidence of bacterial cells in fish macrophage in tissues of spleen, kidney, heart
(endothelial), and peritoneum are evidence of a septicemic condition, suggesting that
macrophages play a key role in the host immune response to L. garvieae infection. However,
intra-macrophage resistance of the bacteria can cause a spread of the pathogen to all
tissues of fish by macrophages. Further, as in the young fish phagocytosis by macrophage
activation may not be sufficient, thus, pathogenesis is a determinant factor, and the disease
can progress.
Several factors play roles in the virulence of L. garvieae. Polysaccharide capsule
is the major virulence factor in L. garvieae infection [29]. The capsulated strains resist
to phagocytosis, but some non-capsulated strains are pathogenic in fish causing high
mortality in rainbow trout [34], thus, the bacterial capsule may not the sole determinant
of the bacterial pathogenicity. Haemolytic toxin is known to cause mortality in fish via
intramuscular injection and an intracellular toxin with a low leukocidal activity reported by
the bacterial isolates recovered from the diseased fish [35]. Plasmids of the virulent isolates
c ntain a protein with an enzymatic dom in corresponding t the family of actin-ADP-
ribosyltransferases [36] that can kill eukaryotic cells by transferring ADP-rib se to ess ntial
proteins [37]. The toxicity t is protein in fish however, warranted future research
works. The presence of putative s t of virulence factor genes (hly1, hly2, hly3, n x, sod,
pavA, psaA), and proteins of olase, lactate d hydrogenas phosphoenolpyruvate-protein
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phosphotransferase with roles in adhesion, cytolytic activity, oxidative stress tolerance,
and metal homeostasis have been detected in strains of L. garvieae, including the avirulent
reference strains ATCC® 49156 and ATCC® 4392, isolates from diseased rainbow trout in
Turkey, France, Iran, Spain, and Italy [38], and fish pathogenic non-capsulated strains in
South Africa [6]. These virulence lifestyle factors can indirectly contribute to host tissue
damage through aiding in the infection process by evasion of the host’s innate immunity,
systemic invasion, cofactor homeostasis, and spreading in the host and adhesion to host
tissues. Further research works need to be directed studying the differential expression
of virulence lifestyle and true virulence genes during growth in the host environment.
Additionally, more studies need to assess the specific virulence factors responsible for the
pathogenicity of L. garvieae, as putative virulence factor genes are present in both the fish
pathogenic isolates and the avirulent isolates.
L. garvieae can invade a wide range of fish species both in warmwater, cold-water,
freshwater and marine aquaculture species including Japanese eel (Anguilla japonica), Nile
tilapia (Oreochromis niloticus), Red sea wrasse (Coris aygula), Pintado (Pseudoplathystoma
corruscans), olive flounder (Paralichthys olivaceous), amberjack (Seriola dumerili) kingfish
(Seriola quinqueradiata), rainbow trout (Oncorhynchus mykiss), grey mullet (Mugil cephalus),
catfish (Silurus glanis), freshwater prawn (Macrobrachium rosenbergii), bottlenose dolphin
(Tursiops truncates), and common octopus (Octopus vulgaris) worldwide [11,35,36,39–44].
The ability of the pathogen to adapt and survive in many environmental conditions is
associated with its wide geographical distribution, it has been isolated from different
aquatic and terrestrial animals [32,40,41,45,46], from rivers and sewage waters [47], and
from different food and feedstuffs.
2.1.1. Current Problems Associated with L. garvieae Infection
Frequent Re-Infection and Temporary Treatment
Several antibiotics, such as erythromycin, spiramycin, kitasamycin, josamycin (macrolide
antibiotics), oxytetracycline, doxycycline, enrofloxacin, florfenicol, lincomycin, and amoxi-
cillin, have been used to treat the disease caused by L. garvieae in fish farms [11,29,48,49].
One of problems with antibacterial agents is that they exhibit a well in vitro function to-
wards L. garvieae, but their use in fish farms is not satisfied because of the loss of appetite of
affected fish [50] or may be due to an ineffective metabolism of antibiotics in the diseased
fish [3].
A following problem with chemotherapeutic treatment of lactococcosis in aquacul-
ture is the increase in bacterial resistant [24,48], and multiple resistance to erythromycin,
lincomycin, and oxytetracycline has been frequently reported in L. garvieae aquatic iso-
lates [48,49,51,52] or to clindamycin, ampicillin and gentamicin in human isolates [53].
Development of R plasmids isolated from erythromycin-, lincomycin- and oxytetracycline-
resistant L. garvieae isolates, macrolides, lincomycin, and tetracycline, or chloramphenicol
have been reported [51,52]. The frequent re-infections of lactococcosis is also another
limitation and constrain encountered with the disease in aquaculture, due to the formation
of tissue granulation in different organs making the treatment become temporary [29,54].
In addition, a frequent treatment of diseased fish can cause an accumulation of antibiotics
in the fish carcass raising a public health problem [55]. Further, the release of the drugs in
the aquatic ecosystems can raise a development of bacterial resistance [56–59]. It is also
very important to administrate the antibiotics of choice that is time-effective due to the
fact that the time required for the bacterial isolation and antibiogram susceptibility tests
as administration of unselective chemical compounds can increase the risk drug spread-
ing in the aquatic environments. Thus, areas of the poor efficiency of chemotherapeutic
agents under field conditions, the risks associated with the spread of antibiotic resistance
determinants, and other methods of treatment or prevention are required further research
studies. Prevention by vaccination is considered the best option to control lactococcosis,
but there are still several limitations with the available vaccines, e.g., limitation of duration
of immunization, required local or regional vaccines using different strains of the bacterium
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(autogenous vaccines), and no strong efficacy by bath vaccination compared to injection
route [29,50,54,60,61].
L. garvieae as Zoonotic Disease
Disease caused by L. garvieae was first as the causative agent of subclinical mastitis in
cattle, and is known as the infection agent in other ruminants and pneumonia in pigs [62,63].
Implication of L. garvieae in human clinical infections has been well demonstrated [63,64],
and during recent years, several human infections by L. garvieae via handling and inges-
tion of raw fish have been reported [63], rising the status of the disease as an emerging
zoonotic agent. The affected humans show endocarditis, bacteremia, hip prosthetic in-
fection, cholecystitis, meningitis, urinary infection, espondilodiscitis, osteomyelitis, liver
abscess, peritonitis, or bacterioascites [63,65–67]. In the case of human infective endo-
carditis, up to 2019, more than twenty-five cases of L. garvieae as the cause of infective
endocarditis have been reported in the literature and compared to other Gram-positive
cocci, L. garvieae affects more frequently patients (16%) with prosthetic valves compared
to infective endocarditis (15.7%) caused by streptococcal members [67–71]. In a recent
study by Malek et al. [71], infection by L. garvieae has been reported as an unusual cause of
infective endocarditis in a 50-year-old male with mitral prosthetic valve and intracranial
haemorrhage that was successfully treated using a combination of lindamycin, ancomycin,
gentamicin, and ceftriaxone. The disease agent can be transmitted from aquatic products
to human; thus, the role of foodborne transmission is still an important route of disease
transmission to human [46,72] as some strains of L. garvieae with fish or shellfish source
are responsible for human infections [73]. Studies demonstrating the host-specificity are
essential to clarify the link between occurrence of the disease in aquaculture species and
human infections especially in the regions where farmers are growing highly susceptible
fish species, such as rainbow trout. For instance, from 64 fresh rainbow trout samples
collected from fish market in Iran, 23.43% (15 samples) were positive for L. garvieae in
their internal or muscles organs indicating the role of market contaminated fish in the
transmission of disease to consumers [74]. Overall, despite its primary role as a bacterial
fish pathogen [29], evidences of septicemia, endocarditis, and osteomyelitis caused by L.
garvieae in humans raises the consumption of the infected fish as a major risk factor in
humans, thus, in fish populations in which disease occurs, necessary attentions must be
made prior to offering the fish for human consumption.
Economic Significant
Among the huge losses of production in aquaculture industry, the outbreaks by
infectious diseases are the most serious problem that causes significant loss to aquaculture
farmers, decrease food insecurity and incomes, and loss of job. It is reported that about
50% loss of aquaculture production is due to outbreaks by infectious diseases which are
more severe in developing countries. The annual loss by infectious disease is up to USD
6 billion [75]. For example, about 15% of the total fish aquaculture production in China is
lost due to disease outbreaks [76]. Such calculations are, however, rough estimation and, it
is, therefore, crucial important to emphasize that there is not an actual annual estimation of
economic losses caused by infectious diseases in global aquaculture. Even in the case of
individual infectious disease, such as L. garvieae, there are no calculated data presenting
an estimated loss in aquaculture sector. The economic impact by lactococcosis in farmed
fish is, however, very high, especially in the regions where the susceptible species are
cultured. For instance, based on our 20-year experience on farmed trout, the annual loss by
the disease outbreaks in Iranian farmed trout is about USD 23 million that is associated
with certain predisposing factors, such as poor health management and poor water quality,
as well as growing of the susceptible species, rainbow trout, in this country. Even in
developed countries, such as Japan, the economic losses caused by infectious diseases
including lactococcosis was exceeded JPY 20 billion (USD 0.18 billion) prior to 1996 [77].
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The annual estimation loss by L. garvieae in farmed fish is, therefore, a gap and required a
necessary evaluation worldwide.
With new approaches in the biotechnology of vaccine production, there is a hope to
control the diseases that impact the economics of the aquaculture sector. Thus, vaccination
can be considered as the best choice to protect the fish farms from lactococcosis outbreaks,
due to the poor efficiency of antimicrobial drugs in fish farms. Vaccination is a good
tool to prevent the risks of spreading of antibiotic resistance factors [29]. However, use
of autogenous vaccines against L. garvieae are more recommended due to their higher
protection compared to non-autogenous vaccines [50]. Additionally, it is recommended
to use such vaccines in combinations with the adjuvants/ or immuno-stimulators, e.g.,
probiotics, prebiotics, and medicinal herbs for ensuring a longer period of protection [29,78].
More details of different adjuvant formulations and immuno-stimulators are given by
Vendrell et al. [29] and Soltani et al. [78]. It is, however, important to use a booster
vaccination once an autogenous vaccine is in use because the efficacy of the available
anti-L. garvieae vaccines is 5–6 months [78]. In addition to immunization, the frequency of
lactococcosis outbreaks and level of morbidity and mortality can be reduced by improving
the health management criteria and farm biosecurity, including enhancement of water
quality parameters, especially water treatment; and avoiding overcrowding, overfeeding,
and overhandling. As L. garvieae has a wide natural source including both warm-blooded
and cold-blooded animals, disinfection of the water source used for aquaculture activity
can significantly reduce the load of the bacterial agents in the water column.
2.2. Diseases Caused by Other Species of Lactococcus Genus
L. lactis strains are genetically classified into four subspecies of lactis, cremoris, tractae,
and hordniae [13]. It is not a common veterinary pathogen, although it can cause cattle mas-
titis and be involved in septic arthritis of the neonatal calf. For example, several variants of
L. lactis have been associated with bovine mastitis [79]. In humans, it has been reported as
a cause of endocarditis, arthritis, and septicemia in patients, although this requires more
clarification [80–84]. Up to date, there are only four reports of lactococcosis by L. lactis in an
aquatic organisms. The first report was an outbreak of white tail disease in cultured giant
freshwater prawn (Macrobrachium rosenbergii) in Taiwan [85]. The affected prawns were
cloudy and whitish in the muscles, showing remarkable edema and necrosis and inflam-
mation in the muscles and hepatopancreas. In subsequent report by Chen et al. [23] L. lactis
subsp. Lactis was isolated from affected hybrid sturgeon, Bester (Huso huso x Acipenser
ruthenus) with signs of anorexia, pale body color, reddish spots on the abdomen, enteritis,
enlarged abdomen, rapid respiration rate ascites, and 70%–100% mortality. Microscopically,
the affected sturgeons demonstrated extensive haemorrhagic multifocal necrotic foci of
spleen and liver with degeneration of hepatic cells, lipid droplets and glycogen granules,
necrosis and renal tubule epithelial swelling and hydropic degeneration in kidney, skin
ulcers deep in underling muscles, appearance of present of immunocompetent cells in the
stomach, and small focus on tips of gills and on the myocardium [23]. No histopathological
changes were, however seen in the eyeball, cerebrum and meninges of affected fish. The
third report was from silver carp (Hypophthalmichthys molitrix) with extensive skin lesions
near the caudal peduncle and musculoskeletal lesion in the USA [86]. The fourth outbreak
of infection by L. lactis has been reported as the cause of endocarditis valvularis, parientalis
thromboticans in mature allis shad (Alosa alosa) in Europe in 2018 that could be associ-
ated with the stressors, such as capturing, transport, breeding, and low oxygen level [87].
Although, in some cases the disease was reproduced experimentally, the mechanisms of
pathogenesis by L. lactis in aquatic animals warranted future research works.
The first and only report of L. piscium as the cause of disease in fish was by Williams et al. [88]
who isolated the bacterium from affected rainbow trout named pseudo-kidney disease [24].
In our best knowledge, the direct involvement of the bacterium as a fish disease agent has
never been evidenced due to no pathogenicity evidence for the isolated strains. The bac-
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terium has also never again been isolated or identified by culture-independent techniques
in the fish intestine microbiota.
The only report of L. raffinolactis infection in fish has been reported as a fish commensal
or an opportunistic pathogen [89], but there are no further data regarding its pathogenic
function in fish.
3. Phytotherapy of Lactococcosis in Aquaculture
3.1. In Vitro Studies
Almost all in vitro studies with vegetable and lichens extractives were performed
against L. garvieae. For convenience, details of in vitro and in vivo studies have been in-
cluded in Tables 1 and 2. Overall, extracts do not show strong antibacterial activity against
L. garvieae, but essential oils are more effective, mainly those that contain thymol or car-
vacrol. There are some differences on minimum inhibitory and bactericidal concentrations
for the same extractive in different studies (Table 1). This may be due to the use of different
bacterial strains or parts or chemotypes of the same plant. According to Ríos and Recio [90],
for vegetable extractives in vitro experiments with concentrations higher than 1000 µg
mL−1 for extracts or 100 µg mL−1 for isolated bioactive compounds should be avoided,
and concentrations below 100 µg mL−1 for extracts and 10 µg mL−1 for isolated bioactive
compounds can be considered very promising.
The aqueous, methanolic and ethanolic extracts of the aerial parts, fresh fruits, or
leaves of 65 plants from Turkey showed weak or non-significant activity against L. garvieae
obtained from Dr. Altınok, Sürmene Faculty of Marine Science, Karadeniz Technical Uni-
versity, Trabzon, Turkey by the disc diffusion method [91–93], and only the ethanolic extract
of dwarf periwinkle (Vinca minor) presented moderate activity against this bacterium [92].
Experiments using the disc diffusion assay with the methanolic, acetone, and aqueous
extracts of 13 lichen species demonstrated that only the methanolic and acetone extracts
of oak moss (Evernia prunastri), cartilage lichens (Ramalina farinacea and Ramalina fraxinea)
and beard lichen (Usnea florida), and acetone extract of lung lichen (Lobaria pulmonaria)
demonstrated moderate activity against L. garvieae [94]. The dichloromethane, methanolic
and ethyl acetate extracts of the aerial parts of Aster (Jurinea humilis) showed weak activity
in vitro against L. garvieae A4 strain [95]. The ethanolic extracts of Persian violet (Cyclamen
pseudibericum), hardy cyclamen (C. hederifolium), and Cilician cyclamen (C. cilicium) also
show no significant activity by disk diffusion assay against L. garvieae recovered from
diseased rainbow trout [96].
Using the same assay demonstrated that the essential oils of the flowers of lavender (La-
vandula angustifolia), everlasting (Helichrysum plicatum), wormwood (Artemisia absinthium),
leaves of pepper mint (Mentha piperita), sweet basil (Ocimum basilicum), wild marjoram
(Origanum majorana), thyme (Thymus vulgaris), spiked thyme (Thymbra spicata), sage (Salvia
officinalis), bay laurel (Laurus nobilis), lemon verbena (Aloysia citriodora), and seeds of black
pepper (Piper nigrum) showed strong activity against L. garvieae strain provided by Dr.
İlhan Altınok (Trabzon, Turkey), while the essential oils of flowers of French lavender (La-
vandula stoechas), yarrow (Achillea millefolium), flower buds of clove (Syzygium aromaticum),
leaves of rosemary (Rosmarinus officinalis), rose geranium (Pelargonium graveolens), parsley
(Petroselinum sativum), river red gum (Eucalyptus camaldulensis), bark of cinnamon (Cinnamo-
mum verum), roots of ginger (Zingiber officinale), and seeds of Chinese parsley (Coriandrum
sativum) showed moderate activity, and the essential oils of leaves of common fennel
(Foeniculum vulgare) and anise (Pimpinella anisum) presented weak activity [97]. Another
experiment with this methodology confirmed the strong activity of the essential oil of
thyme and the moderate activity of the essential oil of rosemary but stated that the essential
oil of bay laurel exhibited a moderate activity against this bacterium [98]. The essential oil
of oregano (Origanum acutidens) (main compound carvacrol) also showed strong activity
against L. garvieae (ATCC 43921) [99]. However, the essential oils of ginger, black cumin
(Nigella sativa), thyme and clove showed weak activity and that of watercress (Eruca sativa)
did not present any activity against L. lactis [100]. The skin mucus of rainbow trout fed
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the ethanolic extract of stinging nettle (Urtica dioica) at 20 and 30 g kg diet−1 for 56 days
inhibited the bacterial growth of L. garvieae in in vitro condition [101].
Under in vitro study we found that essential oil of Shirazi thyme (Zataria multiflora)
(main compound: carvacrol) inhibits the capsule formation of L. garvieae isolates obtained
from diseased rainbow trout because it suppresses the expression of the epsD capsule
gene [102] and the expression of two other virulent factors, the Hly and PavA genes of
the bacterium [10]. In the next study by a microdilution assay on 12 strains of L. garvieae
isolated from diseased rainbow trout exhibited minimum inhibitory concentrations (MICs)
ranging from 160 to 320 µL/mL by essential oils of either Eucalyptus camaldulensis or Mentha
pulegium 60 min post incubation at 25◦C, while no effect was found for Aloe vera essence,
suggesting a potential use of E. camaldulensis and M. pulegium essences against lactococcosis
caused by L. garvieae in farmed fish [103]. In addition, horse mint (Mentha longifolia) essential
oil at 80 µL/mL was more inhibitory towards L. garvieae isolates recovered from diseased
rainbow trout than lower concentrations [104]. Further, by a broth microdilution method,
essential oils of Rosmarinus officinalis and Cuminum cyminum were inhibitory to 11 strains
of L. garvieae recovered from diseased trout with identical MICs ranging from 0.12 to
1.0 µL/mL at 20◦C, 30◦C, and 37 ◦C [105]. More recently we demonstrated that R. officinalis
essential oil (1,8-cineol and α-pinene were the predominant components) was significantly
inhibitory to L. garvieae inoculated on the filet of trout at 0.135% for up to 15 days storage
at 4◦C and best inhibitory effect was seen when the essential oil was used in combination
with nisin at 0.5 µL/mL [106].
It is difficult to compare the level of inhibitory activity of the extractives of medic-
inal herbs and plants with the antibiotics due to several factors involved including the
mode of actions, type of assay and strains of bacterial tested. In their study by Maki et al.
(2008) [107], 146 strains of L. garvieae isolated from diseased yellow tail (Seriola quinqueradi-
ata) in Japan showed varying susceptibility to the 15 chemotherapeutic agents (Table 1), but
no comparative data are available between the antibiotics and the extractives of medicinal
herbs. All strains exhibited identical level of sensitivity to chloramphenicol, florfenicol
and benzylpenicillin, and erythromycin and kanamycin, i.e., sensitive and moderately
resistant, respectively, while in case of erythromycin, 98 strains were sensitive, two strains
were moderately resistant and 46 strains were highly resistant. Against both lincomycin
and tetracycline, 100 strains were sensitive and 46 strains were resistant, while all strains
exhibited susceptibility to new generation of quinolones including ciprofloxacin enoxacin,
floroxacin, norfloxacin, orbifloxacin, and ofloxacin but a low susceptibility to old genera-
tion, i.e., oxolinic acid. The possible reason for highly resistance of about 30% of the strains
to erythromycin could be a frequent treatment of the disease by this antibiotic that has been
used as one of the antibiotic of choice to lactococcosis in fish farmed.
Table 1. Minimum inhibitory concentration (MIC) (µg mL−1 or µL mL−1) and minimum bactericidal concentration (MBC)
(µg mL−1 or µL mL−1) of plant and lichen extractives against Lactococcus garvieae. The portion of the plant used to prepare
the extractives were cited only if stated in the studies. Note: The MIC50 and MIC90 of 15 antibiotics against 146 strains of L.
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0.5 0.5 Soltani et al.,2014
S. quinquera-
diata Chloramphenicol 0.8
a 1.6 b Maki et al., 2008
S. quinquera-
diata Ciprofloxacin 1.6
a 3.13 b Maki et al., 2008
S. quinquera-
diata Erythromycin 0.1
a 800 b Maki et al., 2008
S. quinquera-
diata Enoxacin 6.25
a 12.5 b Maki et al., 2008
S. quinquera-
diata Florfenicol 1.6
a 1.6 b Maki et al., 2008
S. quinquera-
diata Floroxacin 12.5
a 12.5 b Maki et al., 2008
S. quinquera-
diata Kanamycin 25
a 50 b Maki et al., 2008
S. quinquera-
diata Lincomycin 25
a 800 b Maki et al., 2008
S. quinquera-
diata Norfloxacin 6.25
a 12.5 b Maki et al., 2008
S. quinquera-
diata Oxolinic acid 400
a 800 b Maki et al., 2008
S. quinquera-
diata Orbifloxacin 1.6
a 1.6 b Maki et al., 2008
S. quinquera-
diata Ofloxacin 3.13
a 6.25 b Maki et al., 2008
S. quinquera-
diata Penzylpenicillin 0.8
a 1.6 b Maki et al., 2008
S. quinquera-
diata Streptomycin 25
a 50 b Maki et al., 2008
S. quinquera-
diata Tetracycline 12.5
a 400 b Maki et al., 2008
Letters a and b showing MIC50 and MIC90, respectively.
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Table 2. Efficacy of medicinal herbs and plants on the survival of aquatic animals infected with Lactococcus garvieae. The
portion of the plant used to prepare the extractives were cited only if stated in the studies.
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Table 2. Cont.
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these extracts)




1 Aqueous extract was the supernatant of the hot-water extract filtered and centrifuged. The left filtered product and sediment were the dreg
of aqueous extract. 2 survival increase calculated by the equation: (survival treatment × 100)/survival control–100. NS = nonsignificant
difference from control. * TCM = traditional Chinese medicine: composed by the plants Rhizoma coptidis, Radix scutellariae, Cortex phellodendri,
Fructus gardeniae jasminoidis, Fructus forsythiae, and Flos lonicerae japonicae. (a) = Gavage in infected fish twice a day for 10 days. (b) = Injected
in the same day of infection with the bacteria.
3.2. In Vivo Studies
All in vivo studies were related to survival against L. garvieae infection, and, in most
cases, the extractives of medicinal herbs and plants were added to the diets for various
periods before the treated fish being challenged with L. garvieae infection. Overall, the
essential oils that showed the best in vitro antibacterial activity against L. garvieae (Table 1)
were not tested for the in vivo bioassays yet. The extractives tested under in vivo conditions
presented moderate in vitro antibacterial activity against this bacterium or even were
not tested in vitro. However, the dietary supplementation with all tested extractives
reduced mortality of infected animals (Table 2), probably because they improved immune
parameters before challenging the treated fish with L. garvieae. A 12-day feeding giant
freshwater prawn (Macrobrachium rosenbergii) with hot-water extract of water hyacinth
(Eichhornia crassipes) leaves at 1, 2, and 3 g kg−1 diet induced significantly higher survival
rate after challenge with L. garvieae infection, but higher disease resistance was seen
in the prawn treated with higher concentration of the extract [108]. In addition, the
treated animals exhibited an enhancement in the immune responses including respiratory
burst, phenoloxidase activity, superoxide dismutase activity, glutathione peroxidase, total
hemocyte value, differential hemocyte count, transglutaminase activity, and phagocytic
activity towards L. garvtieae. In the subsequent research work by Chang and Cheng [109],
dietary addition of three tested water hyacinth extracts (Table 2) for 120 days increased
survival and immune parameters, i.e., total hemocyte count, semi-granular and granular
cells counts of giant freshwater prawn while phenoloxidase activity, respiratory bursts
of hemocytes were not observed only with dietary addition of powder of this plant to
the diet. Significantly more disease resistance to the pathogen was also obtained in the
animals fed hot-water treated extracts, rather than dried powder, suggesting the suitability
of hot-water extract as a better treatment strategy due to its efficacy and its availability and
convenience. The leaves extract of water hyacinth contains various bioactive compounds
including saponins, polyoses, and alkaloid salts known as the major substances with
immunostimulant effect and antimicrobial activity [110]. The dietary addition of banana
(Musa acuminate) peels aqueous extract at lower (1 g kg diet−1) or higher (6 g kg diet−1)
concentrations for 120 days increased disease resistance of giant freshwater prawn towards
L. garvieae infection [111] that could be in part due to an enhancement effect on the total
hemocyte and granular cells populations, lipopolysaccharide, and β-1,3-glucan binding
protein, transglutaminase, and crustin mRNA expression levels in hemocytes of treated
giant freshwater prawn measured by the authors. Higher concentrations of the plant (3
and 6 g kg diet−1), however, presented higher survival that was correlated with a higher
activity in the phenoloxidase and phagocytic levels [111]. In contrast, giant freshwater
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prawn fed lower dosage (0.6 g kg diet−1) of the aqueous extract of noni (Morinda citrifolia)
for 63 days revealed higher disease resistance towards L. garvieae challenge than the
animals treated with higher concentrations, i.e., 3 and 6 g kg diet−1 [112]. The potency of
the plant on the animal immune responses exhibited that total hemocyte value, differential
hemocyte count, respiratory burst of hemocytes, phenoloxidase, and transglutaminase
activities, as well as the gene expressions of prophenoloxidase, transglutaminase, crustin,
and lysozyme were more stimulated at the lower dosage than the higher ones [112]. These
studies demonstrated that, as can be observed in the review of Elumalai et al. [113], the
immunostimulant effects of herbal compounds and the optimum doses to trigger the
best response are species specific and usually do not follow a dose-response relationship.
Dietary addition of the oil seeds of argan (Argania spinosa) at 5, 10, and 20 mL kg diet−1 for
45 days increased the survival of Nile tilapia (Oreochromis niloticus) after challenge with L.
garvieae infection compared with control fish [114]. At the higher argan oil seeds the survival
of treated fish was, however reduced but was still higher than control group [114]. In all
treatments with this oil, the value of immunocompetent cell size (leucocyte population),
and activities of lysozyme and mieloperoxidase were enhanced pre- and post-challenged
with L. garvieae [114] that could support the fish disease resistance to lactococcal infection.
Apparently, the supplementation with argan oil improved the oil acid profile of the fish
feed, which led to the immunomodulatory effects observed in Nile tilapia [114]. The
dietary addition of the aqueous extract of Shiitake mushroom (Lentinula edodes) at 10 and
20 g kg diet−1 for 45 days enhanced rainbow trout survival challenged with L. garvieae
infection [115]. This response may in part be due to an increase in the number of leucocytes,
myeloperoxidase, lysozyme activity, phagocytic activity, and IgM measured in the treated
fish [115]. Rainbow trout fed dietary supplementation with the aqueous extract of oyster
mushroom (Pleurotus ostreatus) at 10 and 20 g kg diet−1 for 42 days demonstrated higher
survival in challenge with L. garvieae infection that could be due to an enhancement
in the phagocytic, lysozyme, and myeloperoxidase activities, as well as an increase in
immunocompetent cell populations, i.e., neutrophils, monocytes, and total white blood
cells [116]. This effect may be, at least in part, due to the presence of β-glucans in the
oyster mushroom, as these compounds have immunomodulatory effect in fish [117]. The
dietary addition of essential oil of oregano (Origanum onites) in rainbow trout diet at
3.0 mL kg diet−1 for 60 days avoided any mortality in fish post-challenge with L. garvieae
infection [118]. Such a higher survival rate could be due to the stimulation effect of carvacrol
that was the main compound (92.6%) of the essential oil as the treated fish demonstrated a
higher level in the lysozyme activity than the control fish [118]. Eight-week feeding rainbow
trout with stinging nettle (Urtica dioica) at 1%, 2%, and 3% demonstrated an improvement in
the growth, immune responses and antagonistic activity against L. garvieae only in the fish
treated with 2% or 3% of stinging nettle [101], indicating a dosage optimization is required
before any treatment. The in vivo efficacy of the plant to L. garvieae infection is, however
warranted further works. Feeding rainbow trout with tarragon (Artemisia dracunculus)
methanolic extract (aerial parts) at 10, 20, and 30 g kg diet−1 for 56 days demonstrated an
enhancement in the fish mucus bactericidal activity against L. garvieae [119], but data on the
fish disease resistance against lactococcosis caused by L. garvieae warranted further works.
Another preventive treatment was the injection of the essential oils of black cumin
(Nigella sativa) and savory (Satureja bachtiarica) both at 0.417, 0.833, or 1.667 mg kg fish−1
as adjuvant to Streptococcus/Lactococcus vaccine 42 days before infection of rainbow trout
with L. garvieae [120]. However, the vaccinated fish did not show any significant change in
relative survival percentage, antibody levels, and white blood cells number compared to
vaccinated fish without any of the oils [120]. In a unique study by Bilen et al. [121] use of
the methanolic extract of beard lichen (Usnea barbata) at 235, 470, and 705 mg kg fish−1 by
gavage twice a day for 10 days exhibited higher survival than control fish that could be in
part due to the enhancement in the immune related genes (IL-8, TGF-β, IL-12 Beta, TNFα1,
IL-10, COX-2, IL-6, TLR5, C3, IGM, MHC-II, iNOS, IgT, IFN1, IFN2, and IFN reg) in the
infected fish with L. garvieae [121]. The survival of treated fish at higher dosage, i.e., 705 mg
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kg−1 fish however, resulted in no significant difference compared with the control fish, but
the survivals of positive controls (florfenicol and erythromycin each at 353 mg kg−1 fish)
were significantly higher than all treated groups. The two lower doses of this extract also
increased myeloperoxidase activity in the treated fish [121]. These effects may be, at least
in part, due to one of its main compounds, usnic acid, which has immune and antibacterial
effects [122]. Additional studies dealing with dietary supplementation with extractives of
plants or compounds that improve immune parameters in aquatic animals (see reviews
of [107,123,124]) to prevent against L. garvieae, L. lactis and infections are recommended.
Although, herbal medicinal products have been reported as a major source for dis-
covering new pharmaceutical compounds that have been used to treat serious diseases,
studies validating their toxicity are essential prior to be formulated and prescribed as the
therapeutic agents. Unfortunately, minimum data are available concerning the toxicity
and negative side effects of medicinal herb and plants in aquaculture species especially on
commercial fish species. The lethal concentration (LC50) of Eichhornia crassipes in tilapia
(Sarotherodon melanotheron) at 3 h of exposure was 16.37% of the effluent water of the
plant [125], and Morinda cutrifolia at concentrations of 4.8 and 5.4 g/L, aqueous fruit ex-
tract caused a significant histopathological damage in tilapia gills [126]. In their study by
Doleželová et al., 2011 [127] a 96 h LC50 value for Syzygium aromaticum clove oil in Zebra
fish (Danio rerio) and guppy (Poecilia reticulata) were 18.2 ± 5.52 mg/L and 21.7 ± 0.8 mg/L,
respectively. Administration of beard lichen at 5248 µg/L and 1252 µg/L caused abnormal
development of larvae and impairs the growth of sea urchin (Paracentrotus lividus) and
caused 50% mortality in copepod (Tisbe battagliai) at early life stages, respectively [128].
4. Conclusions
Disease outbreaks by Lactococcus species specially L. garvieae is one of the major
concerns faced in the aquaculture production worldwide, and various biological and
environmental variables, as well as the aquaculture practices and husbandry can affect the
quantity and impacts of the morbidity and mortality. Data influencing the economic losses
can, thus, assist to develop policies and strategies to reduce the losses by lactococcosis
outbreaks in aquaculture industry. Lactococcosis outbreaks especially by L. garvieae are
increasingly recognized as a significant and re-emerging bacterial disease in aquaculture,
but there is no an estimation of its economic impacts. Data describing antagonistic activity
and disease resistance efficacy of potential medicinal herbs and plants towards lactococcosis
caused by L. garvieae, L. lactis, L. piscium and L. raffinolactis in finfish are not very much.
Almost all in vitro studies with vegetable and lichens extractives were performed against L.
garvieae. Despite no strong antibacterial activity by herb extracts against L. garvieae, essential
oils especially those that contain thymol and carvacrol are more effective against L. garvieae
strains. The exhibited differences on minimum inhibitory and bactericidal values for the
same extractive in different studies could be due to the use of different bacterial strains or
parts or chemotypes of the same plant. Despite best anti-L. garvieae activity by the essential
oils under in vitro assays, the in vivo bioassays need be assessed yet. The extractives tested
under in vivo conditions presented moderate antibacterial activity against this bacterium
or even were not tested in vitro. However, the dietary supplementation with all tested
extractives reduced mortality of infected animals, probably because they improved immune
parameters before challenging the treated fish with L. garvieae.
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